like HIV diagnoses, the great majority of infections occur among men who have sex with men (MSM). 3 Of interest, in Victoria, increases in HIV notifications have been observed following increases in gonorrhoea notifications. In 1998, 2003 and 2009, gonorrhoea notifications increased by 47%, 44% and 60% respectively on the previous year, 4 followed by increases in HIV notifications in the periods 1999-2000 (41%), 2004-05 (22%) and 2010-11 (21%). 5, 6 Monitoring RG diagnosis trends may act as a tool for anticipating trends in HIV among MSM. Several factors support this hypothesis including, firstly, that RG infection enhances HIV transmission risk. 7 Second, gonorrhoea is highly infectious 8 and may therefore provide a biological proxy indicator for risk behaviours. 9 Third, the majority of urogenital gonorrhoea infections are symptomatic. 8 Finally, there is limited natural immunity from repeated gonorrhoea exposure. 1, 8 These factors, alongside the trends in passive notifications described above, suggest a potential role for gonorrhoea surveillance as a plausible marker of sexual risk behaviours among MSM and a lead indicator of HIV incidence trends. We examined the surveillance potential of RG as a lead indicator of HIV transmission among MSM. There was no correlation between RG and HIV, with the RG-to-HIV lead time of 12 months (r = 0.27; P = 0.28) (Fig. 1) , nor at concurrent (r = 0.04; P = 0.84), 6-month (r = -0.14; P = 0.55) and 24-month lead times (r = -0.09; P = 0.83).
Discussion
This study describes a preliminary examination of the surveillance potential of RG as a lead indicator for trends in HIV positivity. There was no correlation found between RG and HIV, despite previous authors suggesting the monitoring of gonorrhoea to predict trends in HIV transmission. 8 Possible explanations for this are that the limited scope of this study meant that an association could not be detected or that the association hypothesised may not exist. However, the hypothesis remains plausible and offers a potentially more reliable and sensitive lead indicator for HIV transmission in MSM than self-reported risk factors, such as unprotected anal intercourse. The plausibility of a 12-month lead time for RG ahead of HIV is supported by high rates of annual sexually transmissible infection testing self-reported by MSM in Victoria.
between infections in this study, is influenced by testing frequency and is not a true reflection of incidence. Furthermore, MSM may have been tested for RG and HIV at other locations during the period analysed.
We propose that further research at an individual patient level is needed to test the surveillance hypothesis presented here. Establishing a temporal relationship between RG and HIV diagnoses could inform clinical and public health practice, for example by encouraging HIV testing and protective behaviours in those diagnosed with RG. Increases in RG at a population level could also ready public health systems for increases in HIV and inform the timing of investment in social marketing and other HIV prevention initiatives.
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